Immune‐mediated drug‐induced liver injury secondary to Omeprazole: A case report
Abstract Omeprazole is a rare cause of DILI with autoimmune hepatitis features and should be considered when seeing patients with acute liver injury. The causative drug should be promptly identified and discontinued to avoid any permanent liver damage.
Main Authors: | Sara Seife Hassen, Fateen Ata, Ammara Bint I Bilal, Mohamed Salih Ali, Mahir Petkar, Abdelnaser Y. Awad Elzouki, Muhammad Zahid |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-12-01
|
Series: | Clinical Case Reports |
Subjects: | |
Online Access: | https://doi.org/10.1002/ccr3.3421 |
Similar Items
-
Electrolyte disturbances in children receiving omeprazole for gastroesophageal reflux disease
by: Fatemeh Famouri, et al.
Published: (2020-01-01) -
Effects of Omeprazole on Iron Absorption: Preliminary Study
by: Mahmut Yaşar Çeliker, et al.
Published: (2013-09-01) -
Ticagrelor and omeprazole: A desirable combination in post MI patients?
by: Dimitrios Alexopoulos
Published: (2020-09-01) -
Effect of food on the pharmacokinetics of omeprazole, pantoprazole and rabeprazole
by: Dolores Ochoa, et al.
Published: (2020-07-01) -
Omeprazole prescriptions for older adults in health care units in Curitiba, Brazil: an analysis based on Beers Criteria
by: Juliana Sambugaro, et al.
Published: (2021-12-01)